Urinary peptide panel for prognostic assessment of bladder cancer relapse
Magdalena Krochmal(Mosaiques Diagnostics and Therapeutics (Germany)), Maria Frantzi(Academy of Athens), Ellen C. Zwarthoff(Erasmus MC), Harald Mischak(Mosaiques Diagnostics and Therapeutics (Germany)), Kim E.M. van Kessel(Erasmus University Rotterdam), Iwona Belczacka(Mosaiques Diagnostics and Therapeutics (Germany)), Martin Pejchinοvski(Mosaiques Diagnostics and Therapeutics (Germany)), Antonia Vlahou(Academy of Athens)
Cited by 23
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381